Skip to content

Medical emergency? What to do

Edwards heart valve trial results impress

3-RXPublished April 4, 20114 min read

Key points

  • A heart valve replacement technique developed by Edwards LifeSciences Corp that spares patients open-heart surgery had a slightly lower death rate at one year, outweighing a higher risk of major stroke.
  • Non-inferiority of the Edwards device was "strongly established," according to researchers who presented the data at the American College of Cardiology Scientific Sessions.
  • But researchers and doctors said the stroke implications were not yet fully understood and that recovery times and hospital stays were dramatically shorter for patients who do not undergo the procedure in which the chest must be sawed open and the heart stopped.
  • The 699-patient clinical trial, dubbed Partner, compared high-risk elderly subjects who had their diseased aortic valves replaced using the Edwards noninvasive transcatheter valve system with those who had conventional open-heart surgery.

A heart valve replacement technique developed by Edwards LifeSciences Corp that spares patients open-heart surgery had a slightly lower death rate at one year, outweighing a higher risk of major stroke.

One year after implantation using the Edwards valve called Sapien, 24.2 percent of patients died -- compared with 26.8 percent of those who underwent open-heart surgery in the highly anticipated 699-patient study.

Non-inferiority of the Edwards device was "strongly established," according to researchers who presented the data at the American College of Cardiology Scientific Sessions.

The Edwards device led to twice as many major strokes -- 5.1 percent versus 2.4 percent for surgery -- potentially making surgery preferable for some patients.

But researchers and doctors said the stroke implications were not yet fully understood and that recovery times and hospital stays were dramatically shorter for patients who do not undergo the procedure in which the chest must be sawed open and the heart stopped.

"It takes half a year to get back to full activity after open heart surgery. But we see these patients getting mobilized in a few days," said Dr. Mogen Larsen, head of cardiology at Odense University Hospital in Denmark, who has been implanting the Edwards valve, which is approved in Europe, for more than two years.

The 699-patient clinical trial, dubbed Partner, compared high-risk elderly subjects who had their diseased aortic valves replaced using the Edwards noninvasive transcatheter valve system with those who had conventional open-heart surgery.

Dr. Edwin Dizon, a cardiologist at Philippines Heart Center in Manila attending the meeting, called the Edwards valve data "quite impressive" despite the potentially heightened chance of stroke "because the benefit exceeds the risk, and it prolongs life."

In addition to higher stroke risk, 11 percent of patients who got the Edwards valve had major vascular complications after 30 days, compared with 3.2 percent of the surgery group.

But there were also additional clinical advantages seen with the Edwards system, in which the valve is threaded through arteries to the heart with a catheter and implanted inside the old, diseased valve.

New incidences of atrial fibrillation -- potentially dangerous irregular heart rhythms that can lead to stroke and other problems -- occurred in 8.6 percent of those who got the Edwards valve versus 16.0 percent in the surgery group. They also had far less major bleeding than the surgery group -- 9.3 percent compared with 19.5 percent.

A previous study of the Edwards system proved to be far superior to standard drug therapy for aortic stenosis in patients deemed too ill to undergo major surgery.

But it remains to be seen whether the Food and Drug Administration will embrace the new technique in patients for whom surgery remains an option, given the heightened stroke risk seen in the study.

Susan Housholder-Hughes, a nurse practitioner at the University of Michigan in Ann Arbor, is clearly in favor of approval.

"These are elderly patients that don't have much stamina and until now they have had to undergo open heart surgery, which is like getting hit by a truck," she said.

"The less invasive procedure should offer them a quicker recovery and get them back on their feet and doing the things they enjoy and want to do."

Edwards is hoping the totality of the data will work in its favor. The Sapien system is expected to be an important future growth driver for the company, and how widely its use is approved by the FDA will likely be an important factor in just how big a product it can become.

U.S. approval for the Edwards system that is expected to cost about $30,000, and competes with a similar system developed by Medtronic Inc's CoreValve unit in Europe, could come later this year.

Dr Craig Smith, one of the principal researchers of the study, said he expects the Edwards system to help tens of thousands of patients within a short time after U.S. approval and in a few years "hundreds of thousands."

(Reporting by Debra Sherman, Bill Berkrot and Ransdell Pierson; Editing by Eric Walsh, Maureen Bavdek and Gunna Dickson)

###

By Debra Sherman and Bill Berkrot

NEW ORLEANS

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underHeart

Keep reading

Heart

Early sexual abuse increases heart risks

Women who were repeatedly sexually abused as girls have a 62 percent higher risk of heart problems later in life compared with women who were not abused, U.S. researchers said on Sunday. The findings, presented at…

2 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.